A detailed history of Eidelman Virant Capital transactions in Evogene Ltd. stock. As of the latest transaction made, Eidelman Virant Capital holds 117,000 shares of EVGN stock, worth $189,540. This represents 0.07% of its overall portfolio holdings.

Number of Shares
117,000
Previous 117,000 -0.0%
Holding current value
$189,540
Previous $101,000 4.95%
% of portfolio
0.07%
Previous 0.07%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 12, 2022

BUY
$1.09 - $1.83 $4,360 - $7,320
4,000 Added 3.54%
117,000 $152,000
Q4 2021

Feb 01, 2022

BUY
$1.63 - $2.83 $184,190 - $319,790
113,000 New
113,000 $185,000
Q1 2021

Apr 20, 2021

SELL
$4.29 - $9.94 $64,779 - $150,094
-15,100 Closed
0 $0
Q4 2020

Jan 26, 2021

SELL
$2.41 - $5.63 $92,785 - $216,755
-38,500 Reduced 71.83%
15,100 $71,000
Q3 2020

Nov 10, 2020

SELL
$0.97 - $4.08 $10,670 - $44,880
-11,000 Reduced 17.03%
53,600 $219,000
Q2 2020

Jul 10, 2020

BUY
$0.92 - $1.29 $59,432 - $83,334
64,600 New
64,600 $65,000
Q3 2019

Oct 29, 2019

SELL
$1.37 - $1.7 $87,132 - $108,120
-63,600 Closed
0 $0
Q2 2019

Jul 22, 2019

BUY
$1.4 - $2.47 $89,040 - $157,092
63,600 New
63,600 $0

Others Institutions Holding EVGN

# of Institutions
1
Shares Held
117K
Call Options Held
0
Put Options Held
0

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $66.7M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Eidelman Virant Capital Portfolio

Follow Eidelman Virant Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eidelman Virant Capital, based on Form 13F filings with the SEC.

News

Stay updated on Eidelman Virant Capital with notifications on news.